ישראל - עברית - Ministry of Health

taro international ltd, israel - abiraterone acetate - טבליה - abiraterone acetate 125 mg - abiraterone

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - dimetindene maleate 1 mg / 1 ml - dimetindene

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene

ישראל - עברית - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה לאינפוזיה - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - 1.replacement therapy in: primary immunodeficiency syndromes such as: - congenital agammaglobulinemia and hypogammaglobulinemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinemia and recurrent infectionschildren with congenital aids and recurrent infections2. immunomodulation: - idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count- guillain barr? syndrome- kawasaki disease3. allogeneic bone marrow transplantation

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".

ישראל - עברית - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה להזרקה - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbv-dna negative patients ?6 months after liver transplantation for hepatitis b induced liver failure.zutectra is indicated in adults only.the concomitant use of adequate virostatic agents should be considered, if appropriate, as standard of hepatitis b re-infection prophylaxis.

ישראל - עברית - Ministry of Health

csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 900 - 1300 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.

ישראל - עברית - Ministry of Health

csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 1800 - 2600 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.